Novartis cholesterol setback tests hopes for emerging heart disease drugs - Reuters
Novartis cholesterol setback tests hopes for emerging heart disease drugs Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOT3JLc3pSdzFRemdkQjZYMFBtVDNCLVlLSi1qWmEzQ3ZWMldHdEZBOVpLUjJhcXBJZ3pjNWFTY0xpOFNHVVpZVjI3S1dIVHRNRk93bEtPRjc0NTdFTWlpTUJXTngxQ3lCMkxGbW5JTDhMSnhjaVQ1ckZGTm1DbnFYRDh4ck8xOEJPZGJNU0NiZi01Sk1mYnBta2M1ZmlnMV9mRGpJVnlDdkV4c3VuM2J4U0xITGthT3hzNjN0a05hQURpUV90Q1JhMVFsTQ?oc=5" target="_blank">Novartis cholesterol setback tests hopes for emerging heart disease drugs</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMNovartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters
October 2, 2026 at 10:57 AMAI-based drug developer Basecamp valued at $800 million after $140 million funding round - Reuters
AI-based drug developer Basecamp valued at $800 million after $140 million funding round Reuters
September 23, 2026 at 01:08 PMEXCLUSIVE: Anthropic quietly sets up biology lab as it ramps AI drug program - Reuters
EXCLUSIVE: Anthropic quietly sets up biology lab as it ramps AI drug program Reuters
September 18, 2026 at 10:55 AMDrugmakers prepare for next phase of space pharmaceuticals as ISS retirement nears - reuters.com
Drugmakers prepare for next phase of space pharmaceuticals as ISS retirement nears reuters.com
September 17, 2026 at 03:36 PMLegend Biotech taps Novartis veteran Zhang as CEO - reuters.com
Legend Biotech taps Novartis veteran Zhang as CEO reuters.com
September 15, 2026 at 08:26 PM